HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian Chang Selected Research

APO protocol 2

1/2022Characteristics and Outcomes of Chinese Children With Advanced Stage Anaplastic Large Cell Lymphoma: A Single-Center Experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian Chang Research Topics

Disease

15Neoplasms (Cancer)
01/2022 - 01/2015
4Hepatoblastoma
03/2020 - 07/2013
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 10/2019
3Neuroblastoma
02/2019 - 02/2014
3Carcinogenesis
10/2015 - 01/2015
2Hypoxia (Hypoxemia)
01/2022 - 01/2019
2Lung Neoplasms (Lung Cancer)
01/2020 - 01/2015
2Adenoma (Adenomas)
10/2019 - 10/2015
1Disease Progression
06/2022
1Autoimmune Diseases (Autoimmune Disease)
06/2022
1Ulcerative Colitis
06/2022
1Inflammation (Inflammations)
06/2022
1Rupture
01/2022
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2022
1Pleural Effusion (Pleural Effusions)
12/2021
1Ascites
12/2021
1Lymphoma (Lymphomas)
12/2021
1Pericardial Effusion
12/2021
1Kidney Diseases (Kidney Disease)
12/2021
1Conversion Disorder (Astasia Abasia)
07/2021
1Capillary Leak Syndrome
02/2020
1Wilms Tumor (Wilm's Tumor)
02/2020
1Microsatellite Instability
10/2019
1Colorectal Neoplasms (Colorectal Cancer)
10/2019
1Second Primary Neoplasms (Neoplasms, Second)
02/2019
1Infarction (Infarctions)
01/2019
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019
1Residual Neoplasm
10/2018
1Atherosclerotic Plaque (Atheroma)
01/2018
1Sclerosis
01/2018
1Hyperhomocysteinemia
01/2018
1Atherosclerosis
01/2018
1Pathologic Constriction (Stenosis)
01/2018
1Fibrosis (Cirrhosis)
01/2018
1Glioma (Gliomas)
12/2017
1Ischemia
12/2015
1Colonic Neoplasms (Colon Cancer)
02/2015
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
02/2015
1Ganglioneuroblastoma
02/2015
1Carcinoma (Carcinomatosis)
01/2015

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
06/2022 - 02/2014
4Vincristine (Oncovin)FDA LinkGeneric
03/2020 - 02/2014
3Biological ProductsIBA
06/2022 - 01/2020
3Interleukin-2 (IL2)IBA
01/2022 - 02/2020
2tanshinoneIBA
01/2022 - 01/2019
2MicroRNAs (MicroRNA)IBA
01/2022 - 02/2021
2GraphiteIBA
07/2021 - 02/2014
2Topotecan (Hycamtin)FDA LinkGeneric
03/2020 - 02/2014
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019 - 01/2018
2Dinoprostone (PGE2)FDA Link
10/2015 - 01/2015
2Irinotecan (Camptosar)FDA LinkGeneric
02/2015 - 07/2013
1Infliximab (Remicade)FDA Link
06/2022
1Hemoglobins (Hemoglobin)IBA
01/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2021
1huai qi huangIBA
12/2021
1SulfurIBA
07/2021
1VanadiumIBA
07/2021
1LithiumIBA
07/2021
1Circular RNAIBA
02/2021
1Messenger RNA (mRNA)IBA
02/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2020
1Monoclonal AntibodiesIBA
02/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2020
1GemcitabineFDA Link
02/2020
1LigandsIBA
01/2020
1Cell Surface ReceptorsIBA
01/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1Arachidonic Acid (Vitamin F)IBA
10/2019
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2019
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
10/2019
1TensinsIBA
10/2019
1Superoxides (Superoxide)IBA
01/2019
1ManganeseIBA
01/2019
1hydroxycamptothecinumIBA
10/2018
1homocamptothecinIBA
10/2018
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
01/2018
1LipidsIBA
01/2018
1ArginaseIBA
01/2018
1rheinIBA
12/2017
1AnthraquinonesIBA
12/2017
1Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
12/2015
1Diphtheria ToxinIBA
12/2015
1EP4 Subtype Prostaglandin E ReceptorsIBA
10/2015
1AcidsIBA
02/2015
1Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
02/2015
112-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA
02/2015
113-hydroxy-9,11-octadecadienoic acidIBA
02/2015
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2015
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2015
1Oxidoreductases (Dehydrogenase)IBA
01/2015
1GlucocorticoidsIBA
01/2015

Therapy/Procedure

8Therapeutics
06/2022 - 12/2014
7Drug Therapy (Chemotherapy)
03/2020 - 05/2012
2Chemoprevention
10/2015 - 01/2015
1APO protocol 2
01/2022
1Injections
12/2021
1Quantum Dots (Quantum Dot)
07/2021
1Radiofrequency Ablation
03/2020
1Immunotherapy
10/2019